very few studies accounted for the efects of traditional risk factors, treatment adherence and health behaviors while examining the impacts of PD or GAD in patients with CAD. Consequently, the prevalence of anxiety disorders and their prognostic role in patients with CAD remain unclear, and the current available literature cannot support clear clinical recommendations for the management of PD and GAD in patients with CAD